The story of Viagra and its parent , copyright, presents a tangled picture for potential investors. While the iconic drug initially generated enormous earnings, its protection has lapsed , leading to competing options flooding the landscape . This erosion in value presents a real hurdle for copyright and any fund considering a large stake in the fi